{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:07Z","timestamp":1786118887527,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/mph.0b013e3181483df1","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T03:03:45Z","timestamp":1188443025000},"page":"627-632","source":"Crossref","is-referenced-by-count":31,"title":["Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"29","author":[{"given":"Pierre","family":"Wacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita J.","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Pullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210227","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.98.6.565","article-title":"Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum","volume":"98","author":"Kidd","year":"1953","journal-title":"J Exp Med"},{"key":"R2-10-20210227","first-page":"535","article-title":"L-asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia","volume":"37","author":"Ortega","year":"1977","journal-title":"Cancer Res"},{"key":"R3-10-20210227","first-page":"3893","article-title":"Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group","volume":"39","author":"Ertel","year":"1979","journal-title":"Cancer Res"},{"key":"R4-10-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","article-title":"Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia","volume":"315","author":"Clavell","year":"1986","journal-title":"New Engl J Med"},{"key":"R5-10-20210227","first-page":"5601","article-title":"Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia","volume":"43","author":"Sallan","year":"1983","journal-title":"Cancer Res"},{"key":"R6-10-20210227","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"R7-10-20210227","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.1998.16.8.2840","article-title":"Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study","volume":"16","author":"Harris","year":"1998","journal-title":"J Clin Oncol"},{"key":"R8-10-20210227","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.leu.2401886","article-title":"Treatment of children with early Pre-B and Pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study","volume":"14","author":"Harris","year":"2000","journal-title":"Leukemia"},{"key":"R9-10-20210227","first-page":"9","article-title":"Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia","volume":"1","author":"Nesbit","year":"1979","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R10-10-20210227","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/1097-0142(19820401)49:7<1378::AID-CNCR2820490713>3.0.CO;2-Z","article-title":"Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma","volume":"49","author":"Evans","year":"1982","journal-title":"Cancer"},{"key":"R11-10-20210227","first-page":"335","article-title":"Adverse reactions of L-asparaginase","volume":"4","author":"Cairo","year":"1982","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R12-10-20210227","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.38.1.127","article-title":"Cerebrovascular complications of L-asparaginase therapy","volume":"38","author":"Feinberg","year":"1988","journal-title":"Neurology"},{"key":"R13-10-20210227","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.leu.2401162","article-title":"Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia","volume":"12","author":"Woo","year":"1998","journal-title":"Leukemia"},{"key":"R14-10-20210227","first-page":"589a","article-title":"Anti-asparaginase (ASNase) antibody (Ab) in pediatric patients in high risk ALL study (CCG-1961): correlation of Ab and clinical allergy","volume":"19","author":"Avramis","year":"2000","journal-title":"J Clin Oncol"},{"key":"R15-10-20210227","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1097-0142(197208)30:2<376::AID-CNCR2820300212>3.0.CO;2-4","article-title":"Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli","volume":"30","author":"Ohnuma","year":"1972","journal-title":"Cancer"},{"key":"R16-10-20210227","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0142(197403)33:3<611::AID-CNCR2820330303>3.0.CO;2-U","article-title":"Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase","volume":"33","author":"King","year":"1974","journal-title":"Cancer"},{"key":"R17-10-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1097-0142(19920701)70:1<201::AID-CNCR2820700131>3.0.CO;2-M","article-title":"Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase","volume":"70","author":"Billet","year":"1992","journal-title":"Cancer"},{"key":"R18-10-20210227","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","article-title":"Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study","volume":"76","author":"Crist","year":"1990","journal-title":"Blood"},{"key":"R19-10-20210227","first-page":"304","article-title":"Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase therapy","volume":"34","author":"Kurtzberg","year":"1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R20-10-20210227","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","article-title":"Comparative pharmacokinetic studies of three asparaginase preparations","volume":"11","author":"Asselin","year":"1993","journal-title":"J Clin Oncol"},{"key":"R21-10-20210227","first-page":"567a","article-title":"Anti-asparaginase (ASP) antibodies do not impact event-free survival (EFS) in children with acute lymphoblastic leukemia (ALL)","volume":"18","author":"Woo","year":"1999","journal-title":"J Clin Oncol"},{"key":"R22-10-20210227","first-page":"2663","article-title":"The importance of L-asparaginase (A'ase) in the treatment of acute lymphoblastic leukemia (ALL) in children: results of the EORTC 58881 randomize phase III trial showing greater efficiency of Escherichia coli (E. coli) as compared to Erwinia (ERW) A'ase","volume":"88","author":"Otten","year":"1996","journal-title":"Blood"},{"key":"R23-10-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.leu.2401007","article-title":"Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia","volume":"12","author":"Larson","year":"1998","journal-title":"Leukemia"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181483df1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:58:34Z","timestamp":1786035514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200709000-00010"}},"subtitle":["A Children's Oncology Group Study"],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181483df1","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}